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The use of 2-deoxyglucose for the measurement of regional cerebral glucose utilization in both animals and humans has 
gained widespread application. An attractive aspect of regional brain glucose metabolism is its apparent correlation 
with functional activity in neurons. Animal experiments suggest that this relationship is altered in brain lesions and 
that barbiturate anesthesia may be employed in the detection of brain regions where uncoupling of metabolism and 
neuronal function has occurred. A functional metabolic contrast technique is described that will permit determination 
of regional metabolism that is specifically attributable to neuronal activity. Areas of potential clinical application are 
discussed. 
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The carbon-14-labeled 2-deoxy-D-glucose ({14C)2DG) 
technique of Sokoloff and co-workers {28) has led to 
the characterization of regional cerebral glucose metab- 
olism in animals under a variety of experimental condi- 
tions. Imposed experimental variables as diverse as 
sensory stimulation, systemic drug administration, and 
cortical penicillin application have each revealed alter- 
ations in glucose metabolic utilization patterns that 
reflect characteristic changes in neuronal activity [27]. 
Thus, the [I4C)2DG method has enjoyed widespread 
application as a technique for determining neuronal 
responses to physiological and pathophysiological ac- 
tions. In comparison with previous techniques, the 
method has great advantage in that the entire brain can 
be examined simultaneously in autoradiographic sec- 
tions with considerable histological detail. 
Relation of 2DG Uptake to Synaptic 
Transmission and Its Modulation 
The inferred correlation between neuronal activity and 
regional glucose metabolism is further strengthened 
when one considers the detailed anatomical distribu- 
tion of carbon- 14-labeled 2-deoxyglucose 6-phosphate 
([14C)2DG-6-P) in autoradiographic experiments. 
Gray matter regions with the greatest densiry of synap- 
tic connections have relatively higher rates of glucose 
utilization than those that are predominantly cellular, 
and both have metabolic rates much greater than white 
matter in awake animals [25 ,  28). This hierarchy of 
glucose metabolism is best demonstrated in brain re- 
gions where the various neuronal elements are anatom- 
ically stratified. For example, in neocortex the density 
of labeling following C1*C]2DG utilization is greatest 
over layer IV, a region in which afferent thalamic fibers 
synapse on cortical neurons [ 3 ,  10). Labeling in the 
hippocampus is heaviest in the synaptic molecular layer 
and progressively less intense over the pyramidal cell 
layer, the stratum oriens, and the fornix. 
The correlation of regional { 14C]2DG utilization 
with neuronal activity and the local distributions ob- 
served over dense synaptic areas suggest that the me- 
tabolism underlying synaptic transmission plays a ma- 
jor role in the coupling of glucose utilization and 
neuronal activity. In vitro experiments using the poste- 
rior pituitary have verified the sensitivity of presynaptic 
glucose utilization to depolarization and have further 
demonstrated the critical role of sodium-potassium 
adenosine triphosphatase in this coupling [17). At the 
neural synapse, however, this metabolic response to 
presynaptic activation must be considered within the 
context of the polarity and magnitude of the post- 
synaptic response as well. Presynaptic activity can be 
assumed to be metabolically costly regardless of the 
type of synapse involved. Postsynaptic responses, on 
the other hand, should result in additional energy 
utilization at excitatory synapses, while at inhibitory 
synapses there may be no change in energy consump- 
tion or even a decrease in metabolic demand with pre- 
synaptic stimulation. Thus, changes in overall synaptic 
metabolism should correlate positively with neuronal 
activity at excitatory synapses, while the metabolism of 
inhibitory synapses could increase or decrease with 
activation. 
Experiments in anesthetized animals have demon- 
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strated that electrical stimulation of known inhibitory 
pathways can result in an increase in synaptic 2DG 
accumulation 11, while other studies have demon- 
strated profound attenuation of glucose metabolism 
when postsynaptic inhibitory receptors are activated 
by systemic or local administration of gamma- 
aminobutyric acid agonists 13, 9, 201. The net meta- 
bolic response at inhibitory synapses may depend on a 
number of factors, including the relative contributions 
of presynaptic and postsynaptic elements based on 
their surface areas and cytoplasmic volumes {26}, the 
level of postsynaptic excitation from other sources, and 
still other intervening or modulating mechanisms. 
Thus, it may be speculated that 2DG metabolic studies 
should correlate well with direct excitatory events in 
the brain, while caution should be exercised in the 
functional interpretation of results in cases in which 
a major contribution from synaptic inhibition is ex- 
pected. 
Effects of Barbiturates in Brain Lesions 
Results obtained in our laboratory {6} suggest further 
caveats in the use of 2DG for the estimation of 
neuronal function following brain lesions. When rats 
are studied one week following striatal ibotenic acid 
lesions using the {'*C]2DG autoradiographic tech- 
nique, a zone of decreased labeling is observed in the 
striatum corresponding to the lesion site (Figure, part 
A). Brain regions immediately postsynaptic to the le- 
sion demonstrate increased isotope uptake, as seen in 
the pars reticulata of the substantia nigra (Figure, part 
B). Our original interpretation of these findings was 
that the 20% decrease in 2DG uptake within the lesion 
was attributable to the loss of the intrinsic neurons, and 
that the residual labeling represented metabolism in 
glia and presynaptic terminals of extrinsic neurons 
known to be spared in ibotenic or kainic acid lesions 
[24}. The increased labeling of postsynaptic regions 
could be attributable to disinhibition following the re- 
moval of the predominantly gamma-aminobutyric 
acid-mediated striatal innervation. In order to test the 
latter hypothesis, we studied lesioned rats that had 
been pretreated with the gamma-aminobutyric acid ag- 
onist muscimol. Contrary to our expectations, the de- 
nervated substantia nigra was even less sensitive to 
metabolic suppression by muscimol than the contra- 
lateral, intact nigra. Additionally, the lesioned striatum 
was less affected by the muscimol treatment than the 
control side. Rats pretreated with anesthetic doses of 
pentobarbital demonstrated the same resistance to 
metabolic suppression observed with muscimol, a re- 
sult that indicated that the residual asymmetrical 2DG 
labeling (Figure, parts C and D) was unrelated to synap- 
tic neuronal activity. 
Additional autoradiographic studies were performed 
with ['*C}iodoantipyrine to measure regional blood 
flow. The results of these studies confirm that perfu- 
sion of the lesioned striatum is relatively preserved in 
excitatory neurotoxin lesions and sugRest that the re- 
fractory response of the damaged areas to barbiturates 
is not a consequence of decreased drug delivery. 
Another feature that is common to both the striatal 
lesion and its projection sites is the presence of de- 
generating neuronal structures associated with an 
infiltrate of phagocytic cells. We therefore interpret the 
results to indicate that the appearance of barbiturate- 
insensitive 2DG labeling is a reflection of the cellular 
inflammatory process and may well be characteristic of 
the subacute cerebral response to a variety of insults, 
including ischemic infarction and encephalitis. When 
cerebral metabolism was studied with a 10 minute 
['*C}glucose pulse, a much greater impairment of 
isotope accumulation was observed in the lesion (a 
50% decrease) (Figure, part E), in comparison to the 
2DG data. An attractive explanation for both the bar- 
biturate resistance and the difference observed be- 
tween labeled glucose and 2DG is the presence of 
anaerobic glycolysis within the inflammatory infiltrate. 
Studies in both neutrophils and monocytes have dem- 
onstrated dramatic increases in metabolism during 
phagocytosis 122, 231. Basal adenosine triphosphate 
generation in these cells is largely via anaerobic glycoly- 
sis, even in the presence of high oxygen concentra- 
tions. Phagocytosis and lysosomal activation are associ- 
ated with both increased oxygen consumption and 
increased glucose utilization via the hexose mono- 
phosphate shunt pathway to produce the reduced 
nicotinamide-adenine dinucleotide phosphate that is 
presumed necessary for peroxide synthesis. Thus, we 
would anticipate both increased glycolytic activity and 
increased oxygen utilization in cerebral phagocytes fol- 
lowing injury. 
Potential Application in Studies of Cerebral 
Infarction and Other Disorders 
With the recent advent of positron emission tomo- 
graphic (PET) methods capable of imaging the human 
brain and the development of rapid radiochemical 
syntheses of positron-emitting glucose analogs, the 
2DG technique has been applied to a variety of clinical 
research problems. The extension of the beta emitter- 
based autoradiographic method to emission tomog- 
raphy presents advantages beyond the obvious fact that 
it permits us to study regional metabolism of the hu- 
man brain. PET technology also permits us to perform 
repetitive studies in the same subject. The problem of 
inherent variability among subjects is thereby elimi- 
nated. The design of PET protocols that compare re- 
sults obtained in the same subject under varying condi- 
tions is particularly attractive. The principle of using a 
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Color-coded autoradiographs of coronal sections of rat brain seven 
days following ibotenic acid lesion of the right striatum. (A, B)  
Uptake of carbon-14-labeled 2-deoxyglucose ({14C}DG) in awake 
animal. Tracer accumulation is decreased in the lesion (A) and 
increased in the denervated substantia nigra (B). (C, 0) Uptake 
of {I4C}2DG in animal anesthetized with barbiturate. Both the 
lesion (C) and the ipsilateral substantia nigra (0) appear resis- 
tant to the metabolic suppression observed following barbiturate 
administration. (E ,  F )  {'4C}Glucose labeling. Note the greater 
decrease in labeling in the lesion (E) than was observed with 
2DG (A). No asymmetry is observed in the substantia nigra (F). 
Film densities were converted t o  pseudocolor images using a com- 
puter-assisted scanning densitometry facility at the neuroscience 
laboratories of the University of Michigan and the method de- 
scribed by Goochee and co-workers 171. Areas of highest isotope 
uptake are white and red. Yellow, green, blue, and violet corre- 
spond to progressively decreasing concentrations of isotope in the 
tissue underlying the autoradiographic film. 
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subject as his or her own control has in fact been dem- 
onstrated previously in animal studies with hydrogen- 
+labeled and carbon- 14-labeled deoxyglucose, using a 
sequential double-label method f21. In addition, the 
ability to follow regional time-activity curves using 
sensitive tomographs with good temporal resolution 
makes PET 2DG studies much less dependent upon 
assumed kinetic constants derived from control popu- 
lations [8]. Thus, while the spatial resolution of PET 
2DG scans is well below the microscopic level 
achieved in autoradiographic studies in animals, it pos- 
sesses distinct advantages. For example, the compari- 
son of sequential PET studies with and without barbi- 
turate anesthesia (a barbiturate contrast method) will 
allow the determination of regional metabolism di- 
rectly coupled with neuronal function. This procedure 
should provide greater specificity in the interpretation 
of results than that obtained from a single scan. Addi- 
tionally, the regional distribution of barbiturate- 
insensitive metabolism may itself be of interest, as sug- 
gested by the previously described animal study. 
The results in ibotenate-treated animals appear to be 
directly applicable to a number of clinical problems 
using the new noninvasive techniques. In particular, 
questions regarding the pathophysiology of brain isch- 
emia and infarction can be addressed. O n  the basis of 
information obtained thus far, it is now clear that en- 
ergy metabolism of the brain and cerebral blood flow 
can be dissociated in pathological states 113, 14, 16, 19, 
29, 30). Conditions under which there is regional isch- 
emia in the presence of relatively normal rates of brain 
metabolism (poverty perfusion) as well as those in 
which there is increased cerebral blood flow relative to 
energy metabolism (luxury perfusion) have been docu- 
mented. Increased oxygen utilization following stroke 
has been interpreted to indicate peroxidative and 
otherwise energy-consuming steps associated with the 
destruction and removal of damaged tissue by reactive 
cells 1291. An increase in regional glucose utilization 
[13} has been interpreted to indicate increased glyco- 
lytic activity, which is thought to be relatively minor 
in the energy economy of normal brain tissue. As dis- 
cussed previously, both of these metabolic alterations 
have been observed in the inflammatory cells that are 
expected in response to cerebral infarction. A sequen- 
tial contrast study in a patient with a recent stroke using 
positron-labeled 2DG or molecular oxygen in the pres- 
ence and in the absence of barbiturate should clearly 
distinguish normally functioning neuronal tissue from 
other metabolic activity, which should be insensitive to 
the effects of barbiturate anesthesia. 
The 2DG-barbiturate animal experiments reviewed 
here indicate not only that the primary site of injury is 
refractory to the suppressive effect that barbiturates 
have on normal neuropil but also that changes occur in 
afferent projections from the damaged tissue. Present 
evidence suggests that these latter changes may, like 
the primary site, reflect reactive and resorptive pro- 
cesses. We can thus expect that anesthetized subjects 
with an infarcted cortical zone will also manifest in- 
creased 2DG utilization in the thalamus and other sub- 
cortical regions. 
The contrast principle espoused here may prove of 
interest in a number of other disorders. For example, 
the nature of the hypometabolic region surrounding an 
epileptic focus [ S ,  111 is presently unexplained. If it 
represents, in part, replacement of normal functioning 
neural tissue with reactive cells or gliotic scar, this 
change should be demonstrable by a metabolic contrast 
study. 
It will also be of great interest to learn whether the 
comparison of regional brain glucose utilization in the 
awake and in the sedated state varies as a function of 
age. While it is known that the brain decreases in size 
with age 141 and that cerebral blood flow decreases as 
well [15, 1 S}, there is no unanimity regarding the ques- 
tion of whether or not systemic changes in energy me- 
tabolism also occur. While evidence has been reported 
for a decrease in glucose metabolism in cortical tissues 
[12], there does not appear to be agreement regarding 
a commensurate decrease in oxygen utilization. This 
possible discrepancy could be explained in a number of 
ways, for example, by a switch to an alternative fuel, 
such as to ketone body metabolism. On the other hand, 
the discrepancy could reflect increased microsomal or 
lysosomal oxygen metabolism unrelated to adenosine 
triphosphate generation. 
The use of anesthesia carries with it possible risk to 
the subject, so that it will be important to learn 
whether deep sedation is required to produce a sub- 
stantial metabolic decrement. The recent introduction 
of improved synthesis of ["C]2DG makes it feasible to 
perform sequential studies in a single day 12 11, whereas 
with fluorine- 18-labeled fluorodeoxyglucose ( "FDG) 
at least 9 to 10 hours are required between studies to 
allow the first dose of "FDG to decay sufficiently be- 
fore the second study can be performed. For data anal- 
ysis of contrast studies, it is important that the same 
tomographic slice levels be compared and that compa- 
rable brain regions be accurately identified in scan re- 
gions subjected to quantitative analysis. Ideally, the 
head would be held immobile or would be reinserted 
into a head-holder with great precision, so that accurate 
subtraction images could be made. Recent progress in 
the subtraction of PET images in oxygen-15 studies 
gives encouragement that this goal may eventually be 
achieved. The use of ["C]2DG, together with ad- 
vances in PET image registration, will unquestionably 
make the contrast method even more powerful in iden- 
tifying pathological brain tissue. 
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